Operating Profit Cambiamento Data
Acadia Pharmaceuticals USD 34.94M 92.72M 2023-12
Alnylam Pharmaceuticals USD -116404000 330.27M 2023-12
Amarin USD -21451000 2.51M 2023-09
BioCryst Pharmaceuticals USD -11921000 37.8M 2023-09
BioMarin Pharmaceutical USD 14.22M 11.44M 2023-12
Esperion Therapeutics USD -27533000 9.52M 2023-09
Galectin Therapeutics USD -9166000 163K 2023-09
Halozyme Therapeutics USD 101.04M 12.76M 2023-12
Incyte USD 187.27M 27.44M 2023-12
Insmed USD -178272000 30.6M 2023-12
Ionis Pharmaceuticals USD 20.68M 166.04M 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
PTC Therapeutics USD -131738000 13.57M 2023-12
Sarepta Therapeutics USD -48342000 16.82M 2023-09
Ultragenyx Pharmaceutical USD -122049000 23.05M 2023-12
United Therapeutics USD 260.1M 66.9M 2023-12



DBV Technologies L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.